One of this week's biggest Xbox releases is Code Vein 2, which brings its action-RPG / soulslike sequel to Xbox Series X and Xbox Series S on January 29th, and the review scores are a bit all over the ...

William Parks is a Game Rant editor from the USA. Upon graduating from the University of Southern California’s School of Cinematic Arts, William entered the realm of fine arts administration, ...

Claude Code generates computer code when people type prompts, so those with no coding experience can create their own programs and apps. By Natallie Rocha Reporting from San Francisco Claude Code, an ...

Over the holidays, Alex Lieberman had an idea: What if he could create Spotify “Wrapped” for his text messages? Without writing a single line of code, Lieberman, a co-founder of the media outlet ...

On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...

OpenJDK project teams will focus work on features such as value types, code reflection, AOT compilation, and structured concurrency in the coming year. Oracle’s Java team in 2026 will work toward ...

When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...

Coursera has agreed to acquire Udemy in a stock-for-stock transaction that will combine two large online learning platforms with consumer and enterprise businesses. Under the terms of the deal, each ...

Dress to Impress Codes (December 2025): Full List of Active Codes, Rewards, and More Dress to Impress Codes (December 2025): Use these codes to unlock free outfits and accessories in the popular ...

Coursera and Udemy announced on Wednesday a landmark merger agreement valued at approximately $2.5 billion, bringing together two of the biggest names in online learning. Coursera will acquire Udemy ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...